Natalie Bezman

Person

Foster City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating HLA-E-expressing cancers by administering antib...
- Patent number 12,077,584
- Issue date Sep 3, 2024
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immune cells having co-expressed shRNAS and logic gate systems
- Patent number 12,037,407
- Issue date Jul 16, 2024
- ARSENAL BIOSCIENCES, INC.
- Jasper Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding antibodies which bind natural kille...
- Patent number 11,981,734
- Issue date May 14, 2024
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human natural killer cell inhibitory receptor group 2A protein...
- Patent number 11,274,150
- Issue date Mar 15, 2022
- Bristol-Myers Squibb Company
- Natalie Bezman
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies against MICA and/or MICB and uses thereof
- Patent number 11,242,393
- Issue date Feb 8, 2022
- Bristol-Myers Squibb Company
- Michelle Renee Kuhne
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS
- Publication number 20240309106
- Publication date Sep 19, 2024
- Arsenal Biosciences, Inc.
- Jasper Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS
- Publication number 20230340139
- Publication date Oct 26, 2023
- Arsenal Biosciences, Inc.
- Jasper Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST MICA AND/OR MICB AND USES THEREOF
- Publication number 20220281980
- Publication date Sep 8, 2022
- Bristol-Myers Squibb Company
- Michelle Renee KUHNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS
- Publication number 20220235380
- Publication date Jul 28, 2022
- Arsenal Biosciences, Inc.
- Jasper Williams
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20220204618
- Publication date Jun 30, 2022
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20220195042
- Publication date Jun 23, 2022
- Bristol-Myers Squibb Company
- Natalie Bezman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-NKG2A ANTIBODIES AND USES THEREOF
- Publication number 20200199226
- Publication date Jun 25, 2020
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST MICA AND/OR MICB AND USES THEREOF
- Publication number 20190315870
- Publication date Oct 17, 2019
- Bristol-Myers Squibb Company
- Michelle Renee KUHNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION OF ANTI-CS1 AND ANTI-PD1 ANTIBODIES TO TREAT CANCER (MY...
- Publication number 20170355768
- Publication date Dec 14, 2017
- Bristol-Myers Squibb Company
- Michael Darron ROBBINS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Natalie Bezman

Person

Patents Grantslast 30 patents

Methods of treating HLA-E-expressing cancers by administering antib...

Immune cells having co-expressed shRNAS and logic gate systems

Nucleic acid molecules encoding antibodies which bind natural kille...

Anti-human natural killer cell inhibitory receptor group 2A protein...

Antibodies against MICA and/or MICB and uses thereof

Patents Applicationslast 30 patents

IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS

IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS

ANTIBODIES AGAINST MICA AND/OR MICB AND USES THEREOF

IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS

ANTI-NKG2A ANTIBODIES AND USES THEREOF

ANTI-NKG2A ANTIBODIES AND USES THEREOF

ANTI-NKG2A ANTIBODIES AND USES THEREOF

ANTIBODIES AGAINST MICA AND/OR MICB AND USES THEREOF

COMBINATION OF ANTI-CS1 AND ANTI-PD1 ANTIBODIES TO TREAT CANCER (MY...